Please login to the form below

Not currently logged in
Email:
Password:

Former Sanofi exec Joseph Devaney joins Astellas

He becomes government affairs and policy, Americas VP

Astellas Joseph DevaneyAstellas has appointed Joseph Devaney as vice president of government affairs and policy for its Americas business.

In this role, Devaney will be responsible for developing, communicating and implementing Astellas' federal and state government strategies in the US, as well as overseeing its engagement activities and policy development.

He joins the Japanese pharmaceutical firm from Sanofi, where he spent the last 20 years in a series of senior positions, including his most recent post as vice president of federal and state relations.

Prior to this, Devaney was director of state government affairs for Sandoz, which joined Novartis in 1996, and served as a research director and chief of staff for the New Jersey General Assembly.

Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals in Washington, DC.

“His role in developing Astellas' strategy on public policy issues being considered by government lawmakers and trade associations will be pivotal in Astellas' growth throughout the Americas.”

13th July 2016

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics